Physician
Josephson Wallack Munshower Neurology PC
Josephson Wallack Munshower Neurology PC was paid $9.72M by Medicaid between Jan 2018 and Nov 2024, across 45 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoJOSEPHSON WALLACK MUNSHOWER NEUROLOGY PC
INDIANAPOLIS, IN 46250
INDIANAPOLIS, IN 46250
33aNPI1740377803assigned 10/09/2006
33bProvider typeNeurology Physician
28Total paid$9.72M
24GClaims152,165
24DCodes billed45
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Neurology Physician providers in Indiana
Rank by total paid#2 of 46
Median peer was paid$99K
This provider vs. median98×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,376 | $376K | |
| 2019 | 18,815 | $1.07M | |
| 2020 | 18,952 | $992K | |
| 2021 | 21,291 | $1.65M | |
| 2022 | 23,514 | $2.11M | |
| 2023 | 24,441 | $2.05M | |
| 2024incomplete | 19,776 | $1.47M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 59,154 | 50,137 | $3.21M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 9.5% | 11,746 | 9,701 | $921K |
| J2323 | Injection, natalizumab, 1 mg | 8.5% | 355 | 206 | $825K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.1% | 19,350 | 16,581 | $691K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.2% | 6,664 | 5,763 | $605K |
| 99205 | Prolong outpt/office vis | 6.2% | 5,690 | 4,964 | $598K |
| 95886 | 5.7% | 10,444 | 6,644 | $553K | |
| 95816 | 5.0% | 4,874 | 4,258 | $488K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 3.8% | 8,218 | 3,967 | $374K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 3.3% | 1,152 | 617 | $319K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.5% | 8,383 | 3,569 | $243K |
| 99223 | Prolong inpt eval add15 m | 2.4% | 3,225 | 2,806 | $237K |
33 more codes
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 2.0% | 2,901 | $192K |
| 95819 | 1.0% | 1,073 | $97K | |
| 95720 | <1% | 889 | $96K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,022 | $47K |
| 95811 | <1% | 613 | $30K | |
| 64615 | <1% | 869 | $28K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 368 | $24K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 400 | $23K |
| 95913 | <1% | 121 | $23K | |
| 95951 | <1% | 676 | $20K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 940 | $15K |
| 95806 | <1% | 449 | $14K | |
| 95718 | <1% | 131 | $8K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 43 | $8K |
| 99152 | <1% | 820 | $6K | |
| 95782 | <1% | 43 | $4K | |
| 95908 | <1% | 255 | $3K | |
| 95909 | <1% | 378 | $3K | |
| 95910 | <1% | 168 | $3K | |
| 92540 | <1% | 29 | $2K | |
| 62323 | <1% | 26 | $2K | |
| 95885 | <1% | 66 | $1K | |
| 99221 | <1% | 35 | $1K | |
| 99220 | <1% | 190 | $540.73 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 25 | $386.21 |
| 96415 | <1% | 16 | $273.89 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 24 | $273.66 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 45 | $136.73 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 15 | $136.43 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 17 | $49.53 |
| 95911 | 0% | 155 | $0.00 | |
| 99217 | 0% | 96 | $0.00 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMATTOX, SUSAN (CFO/CIO)